mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.002 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.003 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
0.003 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.003 |